ABEO - Abeona Therapeutics Inc
5.34
-0.050 -0.936%
Share volume: 597,632
Last Updated: 04-27-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$5.39
-0.05
-0.01%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-15-2024 | 08-12-2024 | 11-14-2024 | 03-20-2025 | 05-15-2025 | 08-14-2025 | 11-12-2025 | 03-17-2026 | |
| Total revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 400.000 K | 0.000 | 5.420 M | |
| Cost of revenue | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 488.000 K | 1.044 M | |
| Gross profit | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 400.000 K | -488.000 K | 4.376 M | |
| nan% | nan% | nan% | inf% | -222.00% | 996.72% | ||||
| Operating expenses | 14.330 M | 17.864 M | 15.345 M | 16.672 M | 19.727 M | 23.092 M | 23.530 M | 25.494 M | |
| Selling general and admin | 7.123 M | 8.646 M | 6.404 M | 7.678 M | 9.786 M | 17.149 M | 19.314 M | 18.782 M | |
| Research and development | 7.207 M | 9.218 M | 8.941 M | 8.994 M | 9.941 M | 5.943 M | 4.216 M | 6.712 M | |
| Total expenses | 14.330 M | 17.864 M | 15.345 M | 16.672 M | 19.727 M | 23.192 M | 23.530 M | 27.287 M | |
| 24.66% | -14.10% | 8.65% | 18.32% | 17.56% | 1.46% | 15.97% | |||
| Operating income | -14.330 M | -17.864 M | -15.345 M | -16.672 M | -19.727 M | -22.792 M | -24.018 M | -22.911 M | |
| Ebit | -31.631 M | 7.063 M | -30.501 M | -9.897 M | -12.482 M | -28.091 M | -21.129 M | 131.169 M | |
| Pretax income | -31.740 M | 7.182 M | -30.414 M | -9.956 M | -12.170 M | 124.345 M | -20.358 M | -20.534 M | |
| -122.63% | -523.48% | -67.27% | 22.24% | -1,121.73% | -116.37% | 0.86% | |||
| Income tax | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 15.512 M | -15.197 M | 0.000 | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | -31.578 M | 7.406 M | -30.269 M | -9.293 M | -12.029 M | 108.833 M | -5.161 M | -20.460 M | |
| 123.45% | -508.71% | 69.30% | -29.44% | 1,004.76% | -104.74% | -296.43% |